PNC FINANCIAL SERVICES GROUP, INC. - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 109 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q4 2022$130200
-22.5%
0.00%
Q2 2022$0258
-80.8%
0.00%
Q1 2022$0
-100.0%
1,3440.0%0.00%
Q4 2021$2,000
-94.6%
1,344
-93.5%
0.00%
Q3 2021$37,000
-42.2%
20,674
-15.5%
0.00%
Q2 2021$64,000
+255.6%
24,458
+377.3%
0.00%
Q1 2021$18,000
+50.0%
5,1240.0%0.00%
Q4 2020$12,0000.0%5,1240.0%0.00%
Q3 2020$12,000
-88.0%
5,124
-83.1%
0.00%
Q2 2020$100,000
-10.7%
30,284
-33.1%
0.00%
Q1 2020$112,000
-21.7%
45,286
+49.3%
0.00%
Q4 2019$143,000
+10.0%
30,3360.0%0.00%
Q3 2019$130,000
+333.3%
30,336
+468.5%
0.00%
Q2 2019$30,000
+42.9%
5,3360.0%0.00%
Q1 2019$21,000
+133.3%
5,3360.0%0.00%
Q4 2018$9,000
-97.5%
5,336
-95.2%
0.00%
Q3 2018$356,000
+6.3%
110,9360.0%0.00%
Q2 2018$335,000
-23.3%
110,936
-0.4%
0.00%
Q1 2018$437,000
-5.4%
111,4360.0%0.00%
Q4 2017$462,000
-32.6%
111,4360.0%0.00%
-100.0%
Q3 2017$685,000
-1.2%
111,4360.0%0.00%0.0%
Q2 2017$693,000
-1.8%
111,4360.0%0.00%0.0%
Q1 2017$706,000
+18.3%
111,4360.0%0.00%0.0%
Q4 2016$597,000
-4.9%
111,436
-0.0%
0.00%0.0%
Q3 2016$628,000
-3.1%
111,457
-5.6%
0.00%0.0%
Q2 2016$648,000
-25.7%
118,038
+0.3%
0.00%0.0%
Q1 2016$872,000
-11.6%
117,640
-0.8%
0.00%0.0%
Q4 2015$986,000
-8.4%
118,619
-0.8%
0.00%0.0%
Q3 2015$1,077,000
-47.0%
119,619
-29.3%
0.00%
-50.0%
Q2 2015$2,031,000
+30.3%
169,210
+16.8%
0.00%0.0%
Q1 2015$1,559,000
+153.9%
144,887
+19.8%
0.00%
+100.0%
Q4 2014$614,000
+100.0%
120,930
+4.4%
0.00%
Q3 2014$307,000
-28.8%
115,886
+8.4%
0.00%
-100.0%
Q2 2014$431,000
-12.2%
106,9300.0%0.00%0.0%
Q1 2014$491,000
+6.3%
106,930
+0.3%
0.00%0.0%
Q4 2013$462,000
+10.0%
106,6000.0%0.00%0.0%
Q3 2013$420,000
+87.5%
106,6000.0%0.00%
Q2 2013$224,000106,6000.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q1 2023
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 12,546,493$22,835,0001.71%
MSD Partners, L.P. 15,151,516$27,576,0000.84%
MSD Partners, L.P. 7,575,758$13,788,0000.42%
CHIRON CAPITAL MANAGEMENT, LLC 198,002$360,0000.26%
Avidity Partners Management LP 3,000,000$5,460,0000.12%
Old West Investment Management, LLC 211,513$384,0000.10%
MAGNOLIA CAPITAL ADVISORS LLC 103,239$188,0000.07%
Virtus ETF Advisers LLC 72,060$131,0000.06%
ACT WEALTH MANAGEMENT, LLC 34,454$91,0000.06%
Allred Capital Management, LLC 53,000$96,0000.05%
View complete list of ZIOPHARM ONCOLOGY INC shareholders